Estrogen receptor beta (ERP) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERα) and prognosis: The Greek experience

Estrogen receptors (ER) are members of the nuclear receptor superfamily of ligand-activated transcription factors and mediate the effects of estrogen on target tissues. ERalpha was the first estrogen receptor to be characterized, and ERbeta was identified ten years later. The role of ERbeta in breast cancer pathobiology is largely unknown because specific antibodies have not been available until recently. The purpose of this study was to explore the expression of ERbeta in breast neoplasms and to correlate it with ERalpha and prognosis. ERa and ERbeta expression was monitored immunohistochemically in 59 breast carcinomas. We found no correlation between ERalpha and ERbeta expression, between ERbeta expression and the known prognostic indicators such as tumor size, grade or lymph node status, or between ERbeta expression and survival. Our findings contribute to the better understanding of the role of ERbeta in breast cancer.

Estrogen receptor beta; Alpha; Breast; ERβ; ERα

[1] Poola I., Abraham J., Baldwin K.: "Identification of ten exon deleted ERβ mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor β mRNA is distinct from that of estrogen receptor a". FEBS Lett., 2002, 516, 133.

[2] Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K. et al.: "The nuclear receptor supefamily: the second decade". Cell, 1995, 83, 835.

[3] Green S., Walter P., Kumar V., Krust A., Borner! J.M., Argos P., Chambon P. "Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A". Nature, 1986, 320, 134.

[4] Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J.: "Sequence and expression of human estrogen complementary DNA". Science, 1986, 231, 1150.

[5] Mosselman S., Polman J., Dijkema R. "ER-β: identification and characterization of a novel human estrogen receptor". FEBS Lett., 1996, 392, 49.

[6] Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A.: "Cloning of a novel receptor expressed in rat prostate and ovary". Proc. Natl. Acad. Sci., 1996, 93, 5925.

[7] Tremblay G.B., Tremblay A., Copeland N.G., Gilbert DJ., Jenkins N.A., Labrie F., Giguere V.: "Cloning, chromosomal localisation and functional analysis of tha murine estrogen receptor β"- Mol. Endocrinol., 1997, 11, 353.

[8] Menasce L.P., White G.R., Harrison C.J., Boyle J.M.: "Localisation of the estrogen receptor locus (ESR) to chromosome 6q25.lby FISH and a simple post-FISH banding technique". Genomics, 1993, 17, 263.

[9] Enmark E., P elto-Huikko M., Grandien K., Lagercrantz S., Fried G., Nordenskjold M., Gustafsson J.A.: "Human estrogen receptor β-gene structure, chromosomal localization and expression pattern". J. Clin. Endocrinol. Metab., 1997, 82, 4258.

[10] Hall J.M., Couse J.P., Corah K.S.: "Th e multifaceted mechanisms of estradiol and estrogen receptor signaling". J. Biol. Chem., 2001, 276, 36869.

[11] Pettersson K., Gustafsson J.A.: "Role of estrogen receptor beta in estrogen action". Annu. Rev. Physiol., 2001, 63, 165.

[12] Pettersson K., Gustafsson J.A.: "Estrogen receptor beta acts as a dominant regulator of estrogen signalling". Oncogene, 2000, 19, 4970.

[13] Paech K., Webb P, Kuiper G.G.J.M., Nilsson S., Gustaffson J.A., Kushner P.J., Scalnan T.S.: "Differential ligand activation of estrogen receptors ERalpha and ERbeta at APl sites". Science, 1997, 277, 1508.

[14] Jakacka M., Ito M., Weiss J., Chien P.Y., Gehm B.D., Jameson J.L.: "Estrogen receptor binding to DNA is not required for its activity through the nonclassical APl pathway". J. Biol. Chem., 2001, 276, 13615.

[15] Moore J.T., McKee D.D., Sietz-Kesler K., Moore L.B., Jones S.A., Home E.L. et al.: "Cloning and characterization of human estrogen receptor β isoforms'. Biochem. Biophys. Res. Commun., 1998, 247, 75.

[16] Pujol P., Rey J.M., Nirde P., Roger P., Gastaldi M., Laffargue F. et al.: "Differential expression of estrogen receptor-α and -β messanger RNAs as a potential marker of ovarian carcinogenesis". Cancer Res., 1998, 58, 5367.

[17] Rutherford T., Brown W.D., Sapi E., Aschenazi S., Munoz A., Mor G.: "Absence of estrogen receptor β expression in metastatic ovarian cancer". Obstet. Gynaecol., 2000, 96, 417.

[18] Chang W.Y., Prins G.S.: "Estrogen receptor－β: Implications for the prostate gland". Prostate, 1999, 40, 115.

[19] Kostantinopoulos P.A., Kominea A., Vandoros G., Sykiotis G.P., Andrikopoulos P., Varakis J. et al.: "Oestrogen receptor beta (ERβ) is abundantly expresses in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumors dedifferentiation". Eur. J. Cancer, 2003, 39, 1251.

[20] Foley E.F., Jazaeri A.A., Shupnik M.A., Jazaeri O., Rice L.W.: "Selective loss of estrogen receptor beta in malignant human colon". Cancer Res., 2000, 60, 245.

[21] Witte D., Chirala M., Younes A., Li Y., Younes M.: "Estrogen receptor beta is expressed in human colorectal adenocarcinoma". Hum. Pathol., 2001, 32, 940.

[22] Speirs V.: "Oestrogen receptor 􀁍 in breast cancer:good, bad or still too early to tell?". J. Pathol., 2002, 197, 143.

[23] McCarty K.S. Jr, Miller L.S., Cox E.B., Keonrath J., McCarty K.S.S.: "Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies". Arch. Pathol. Lab. Med., 1985, 109, 716.

[24] Erunark E., Pelto-Huikko M., Gardien K., Lagercrantz S., Lagercrantz J., Fried G. et al.: "Human estrogen receptor β-gene structure, chromosomal localization and expression pattern". J. Clin. Endocrinol. Metab., 1997, 82, 4258.

[25] Leygue E., Dotslaw H., Watson P.H., Murphy L.C.: "Altered estrogen receptor α and β messanger RNA expression during breast carcinogenesis". Cancer Res., 1998, 58, 3197.

[26] Speirs V., Parkes A.T., Kerin M.J., Walton D.S., Carleton P.J., Fox J.N., Atkin S.L.: "Co-expression of estrogen receptor-a and-β: poor prognostic factors in human breast cancer?". Cancer Res., 1999, 59, 525.

[27] Sasano H., Suzuki T., Matsuzaki Y., Fukaya T., Endoh M., Nagura H., Kimura M.: "Messanger ribonucleic acid in situ hybridisation analysis of estrogen receptors α and β in human breast carcinoma". J. Clin. Endocrinol. Metabol., 1999, 84, 781.

[28] Dotslaw H., Leygue E., Watson P.H., Murphy L.C.: "Estrogen receptor β mRNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestin". Cancer Res., 1999, 59, 529.

[29] Leygue E., Dotslaw H., Watson P.H., Murphy L.C.: "Expression of estrogen receptor 􀁍 1, 􀁍2, and 􀁍5 messenger RNAs in human breast tissue". Cancer Res., 1999, 59, 1175.

[30] Knowelden J.M., Gee J.M.W., Robertson J.F.R., Ellis I.0., Nicholson R.I.: "A possible divergent role for the estrogen receptor alpha and beta subtypes in clinical breast cancer". Int. J. Cancer, 2000, 89, 209.

[31] Vladusic E.A., Hornby A.E., Guerra-Vladusic F.K., Lakins J., Lupu R.: "Expression and regulation of estrogen receptor β in human breast tumors and cell lines". Oneal. Rep., 2000. 7, 157.

[32] lwao K., Miyoshi Y., Egawa C., Ikeda N., Tsukamoto F., Noguchi S.: "Quantitative analysis of astrogen receptor -α andβ messsenger RNA expression in breast carcinoma by real time polymerase chain reaction". Cancer, 2000, 89, 1732.

[33] lwao K., Miyoshi Y., Egawa C., Ikeda N., Nogushi S.: "Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers". Int. J. Cancer, 2000, 88, 733.

[34] Cullen R., Maguire T.M., McDermott E.W., HilI A.O., O'Higgms NJ., Duffy M.J.: "Studies on oestrogen receptor-α and-β mRNA in human breast cancer". Eur. J. Cancer, 2001, 37, 1118.

[35] Speirs V., Malone C., Watson D.S., Kerin M.J., Atkin S.L.: "Increased expression of estrogen receptor β mRNA in tamoxifen resistant breast cancer patients". Cancer Res., 1999, 59, 5421.

[36] Jarniven T.A.H., Pelto-Huikko M., Holli K.. Isola J.: "Estrogen receptor β is co-expressed with ERa and PR and associated with nodal status, grade and proliferation in breast cancer". Am. J. Pathol., 2000, 156, 29.

[37] Omoto Y., Inoue S., Ogawa S., Toyama T., Yamashita H., Muramatsu M. et al.: "Clinical value of the wild-type estrogen receptor β expression in breast cancer". Cancer Lett., 2001, 63, 207.

[38] Skliris G.P., Carder P.J., Lansdown M.R.J., Speirs V.: "Immunohistochemical detection of ERβ in cancer: towards more derailed receptor profiling?". B1: J. Cancer, 2001, 84, 1095.

[39] Skliris G.P., P arkes A.T., Limer J.L., Burdall S.E., Carder P.J., Speirs. V.: "Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue". J. Pathol., 2002, 197, 155.

[40] Mann S., Laucirica R., Carlson N., Younes P.S., Ali N., Younes M.: "Estrogen receptor beta expression in invasive breast cancer". Hum. Pathol., 2001, 32, 113.

[41] Roger P., Sahla M.E., Makela S., Gustaffson J.A., Baldet P., Rochefort H.: "Decreased expression of estrogen receptor P protein in proliferative preinvasive mammary tumours". Cancer Res., 2001, 61, 2537.

[42] Iwase H., Zhang Z., Omoto Y., Sugiura H., Yamashita H., Toyama T. et al.: "Clinical significance of the expression of estrogen receptors a and p for endocrine therapy of breast cancer". Cancer Chemother. Pharmacol., 2003, 52 (suppl. I), 34.

[43] Shaw J.A., Udokang K., Mosquera J.M., Chauhan H., Jones J.L.: "Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas". J. Pathol., 2002, 198, 450.

[44] Saji S., Omoto Y., Shimizu C., Warner M., Hayashi Y., Horiguchl S. et al.: "Expression of estrogen receptor (ER) pcx protein in ERa-positive breast cancer:specifi C correltation with progesterone receptor". Cancer Res., 2002, 62, 4849.

[45] Shaaban A.M., O'Neil P.A., Foster C.S. Letter to the Editor: "Evaluation of seven oestrogen receptor P antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue". J. Pathol., 2003, 199, 130.

[46] Skliris G.P., Munot K., Bell S.M., Carder P.J., lane S., Horgan K. et al.: "Reduced expression of oestrogen receptor P in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model". J. Pathol., 2003, 201, 213.